These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 17156011)
1. Lovastatin possesses a fungistatic effect against Candida albicans, but does not trigger apoptosis in this opportunistic human pathogen. Gyetvai A; Emri T; Takács K; Dergez T; Fekete A; Pesti M; Pócsi I; Lenkey B FEMS Yeast Res; 2006 Dec; 6(8):1140-8. PubMed ID: 17156011 [TBL] [Abstract][Full Text] [Related]
2. The antifungal plant defensin RsAFP2 from radish induces apoptosis in a metacaspase independent way in Candida albicans. Aerts AM; Carmona-Gutierrez D; Lefevre S; Govaert G; François IE; Madeo F; Santos R; Cammue BP; Thevissen K FEBS Lett; 2009 Aug; 583(15):2513-6. PubMed ID: 19596007 [TBL] [Abstract][Full Text] [Related]
3. Melittin induces apoptotic features in Candida albicans. Park C; Lee DG Biochem Biophys Res Commun; 2010 Mar; 394(1):170-2. PubMed ID: 20188067 [TBL] [Abstract][Full Text] [Related]
4. Antifungal effect with apoptotic mechanism(s) of Styraxjaponoside C. Park C; Woo ER; Lee DG Biochem Biophys Res Commun; 2009 Dec; 390(4):1255-9. PubMed ID: 19878645 [TBL] [Abstract][Full Text] [Related]
5. Lovastatin triggers an apoptosis-like cell death process in the fungus Mucor racemosus. Roze LV; Linz JE Fungal Genet Biol; 1998 Nov; 25(2):119-33. PubMed ID: 9974223 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced by environmental stresses and amphotericin B in Candida albicans. Phillips AJ; Sudbery I; Ramsdale M Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14327-32. PubMed ID: 14623979 [TBL] [Abstract][Full Text] [Related]
7. Effects of IgY against Candida albicans and Candida spp. Adherence and Biofilm Formation. Fujibayashi T; Nakamura M; Tominaga A; Satoh N; Kawarai T; Narisawa N; Shinozuka O; Watanabe H; Yamazaki T; Senpuku H Jpn J Infect Dis; 2009 Sep; 62(5):337-42. PubMed ID: 19762981 [TBL] [Abstract][Full Text] [Related]
8. Development of oxidative stress tolerance resulted in reduced ability to undergo morphologic transitions and decreased pathogenicity in a t-butylhydroperoxide-tolerant mutant of Candida albicans. Fekete A; Emri T; Gyetvai A; Gazdag Z; Pesti M; Varga Z; Balla J; Cserháti C; Emody L; Gergely L; Pócsi I FEMS Yeast Res; 2007 Sep; 7(6):834-47. PubMed ID: 17498215 [TBL] [Abstract][Full Text] [Related]
9. Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue. Uppuluri P; Mekala S; Chaffin WL Yeast; 2007 Aug; 24(8):681-93. PubMed ID: 17583896 [TBL] [Abstract][Full Text] [Related]
10. Anti-Candida activity of the anti-cancer drug tamoxifen. Beggs WH Res Commun Chem Pathol Pharmacol; 1993 Apr; 80(1):125-8. PubMed ID: 8488339 [TBL] [Abstract][Full Text] [Related]
11. Effect of suramin on the human pathogen Candida albicans: implications on the fungal development and virulence. Braga-Silva LA; dos Santos AL; Portela MB; Souto-Padrón T; de Araújo Soares RM FEMS Immunol Med Microbiol; 2007 Nov; 51(2):399-406. PubMed ID: 17760875 [TBL] [Abstract][Full Text] [Related]
12. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans. Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687 [TBL] [Abstract][Full Text] [Related]
13. The antimicrobial peptide, psacotheasin induces reactive oxygen species and triggers apoptosis in Candida albicans. Hwang B; Hwang JS; Lee J; Lee DG Biochem Biophys Res Commun; 2011 Feb; 405(2):267-71. PubMed ID: 21219857 [TBL] [Abstract][Full Text] [Related]
14. Damage to the cytoplasmic membrane and cell death caused by lycopene in Candida albicans. Sung WS; Lee IS; Lee DG J Microbiol Biotechnol; 2007 Nov; 17(11):1797-804. PubMed ID: 18092463 [TBL] [Abstract][Full Text] [Related]
15. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole. Bruzual I; Riggle P; Hadley S; Kumamoto CA J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564 [TBL] [Abstract][Full Text] [Related]
16. High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione. Gyetvai A; Emri T; Fekete A; Varga Z; Gazdag Z; Pesti M; Belágyi J; Emõdy L; Pócsi I; Lenkey B FEMS Yeast Res; 2007 Mar; 7(2):265-75. PubMed ID: 17266730 [TBL] [Abstract][Full Text] [Related]
17. Membrane damage as first and DNA as the secondary target for anti-candidal activity of antimicrobial peptide P7 derived from cell-penetrating peptide ppTG20 against Candida albicans. Li L; Song F; Sun J; Tian X; Xia S; Le G J Pept Sci; 2016 Jun; 22(6):427-33. PubMed ID: 27197902 [TBL] [Abstract][Full Text] [Related]
18. Identification of salivary components that induce transition of hyphae to yeast in Candida albicans. Leito JT; Ligtenberg AJ; Nazmi K; Veerman EC FEMS Yeast Res; 2009 Oct; 9(7):1102-10. PubMed ID: 19799638 [TBL] [Abstract][Full Text] [Related]
19. Fungistatic activity of Semecarpus anacardium Linn. f nut extract. Sharma K; Shukla SD; Mehta P; Bhatnagar M Indian J Exp Biol; 2002 Mar; 40(3):314-8. PubMed ID: 12635702 [TBL] [Abstract][Full Text] [Related]
20. Human fungal pathogen Candida albicans in the postgenomic era: an overview. Kabir MA; Hussain MA Expert Rev Anti Infect Ther; 2009 Feb; 7(1):121-34. PubMed ID: 19622061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]